Ouerdani A, Valenzuela B, Treijtel N, Haddish-Berhane N, et al. Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL). Cancer Chemother Pharmacol 2025;95:38.
PMID: 40019563